{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:14:14Z","timestamp":1777601654650,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"crossref","award":["TF_013_20161125"],"award-info":[{"award-number":["TF_013_20161125"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/5\/30177"],"award-info":[{"award-number":["RE\/13\/5\/30177"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1434-7","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T10:02:47Z","timestamp":1562061767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases"],"prefix":"10.1186","volume":"20","author":[{"given":"Benjamin M. P.","family":"Elyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-0178","authenticated-orcid":false,"given":"Jennifer S.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Mackinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin C.","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily P.","family":"McQuarrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"1434_CR1","unstructured":"World Health Organisation. \n                    http:\/\/www.who.int\n                    \n                  . [Online]; 2017. Disponible en: \n                    http:\/\/apps.who.int\/gho\/data\/view.main.GLOBAL2461A?lang=en\n                    \n                  ."},{"key":"1434_CR2","unstructured":"World Health Organization. World Health Organization. [Online]. Geneva; 2000. [WHO Technical Report Series 894]. Disponible en: \n                    http:\/\/www.who.int\/nutrition\/publications\/obesity\/WHO_TRS_894\/en\/\n                    \n                  ."},{"issue":"15","key":"1434_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","volume":"341","author":"EE Calle","year":"1999","unstructured":"Calle EE, Petrelli JM, Rodriguez C, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097\u2013105.","journal-title":"N Engl J Med"},{"key":"1434_CR4","unstructured":"Statistics O. Scottish Government. [Online].; 2017. Acceso 28 de June de 2018. Disponible en: \n                    http:\/\/www.gov.scot\/Publications\/2017\/11\/1691?_ga=2.258674698.1891177112.1530004502-659482484.1530004502\n                    \n                  ."},{"key":"1434_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12882-015-0083-8","volume":"16","author":"X Cao","year":"2015","unstructured":"Cao X, Zhou J, Yuan H, et al. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort. BMC Nephrol. 2015;16:85.","journal-title":"BMC Nephrol"},{"issue":"21","key":"1434_CR6","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1001\/2013.jamainternmed.85","volume":"172","author":"Asaf Vivante","year":"2012","unstructured":"Vivante A, Golan E, Tzur D, Leiba A. Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012;172(21):1644\u201350.","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"1434_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","volume":"144","author":"CY Hsu","year":"2006","unstructured":"Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21\u20138.","journal-title":"Ann Intern Med"},{"issue":"9","key":"1434_CR8","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1681\/ASN.2013070754","volume":"25","author":"JL Lu","year":"2014","unstructured":"Lu JL, Kalantar-Zadeh K, Ma JZ, et al. Association of Body Mass Index with outcomes in patients with CKD. J Am Soc Nephrol. 2014;25(9):2088\u201396.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1434_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.pcad.2013.10.005","volume":"56","author":"J Park","year":"2014","unstructured":"Park J, Ahmadi SF, Streja E, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis. 2014;56(4):415\u201325.","journal-title":"Prog Cardiovasc Dis"},{"key":"1434_CR10","doi-asserted-by":"crossref","unstructured":"Kato S, Nazneen A, Nakashima Y, Razzaque MS. Pathological influence of obesity on renal structural changes in chronic kidney disease. 2009;13(4):332\u201340.","DOI":"10.1007\/s10157-009-0169-3"},{"issue":"4","key":"1434_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/01913123.2011.584657","volume":"35","author":"S Darouich","year":"2011","unstructured":"Darouich S, Goucha R, Jaafoura MH, et al. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis. Ultrastruct Pathol. 2011;35(4):176\u201382.","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"1434_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/jcla.21778","volume":"29","author":"Mamiko Shimamoto","year":"2014","unstructured":"Shimamoto M, Ohsawa I, Suzuki H, Hisada A. Impact of body mass index on progression of IgA nephropathy among Japanese patients. J Clin Lab Anal. 2014;29(5).","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"1434_CR13","doi-asserted-by":"crossref","unstructured":"Wu C, Wang AY, Li G, Wang L. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy. BMC Nephrol. 2018;19(1).","DOI":"10.1186\/s12882-018-1164-2"},{"issue":"5","key":"1434_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s10157-012-0613-7","volume":"16","author":"H Kataoka","year":"2012","unstructured":"Kataoka H, Ohara M, Shibui K, Sato M, Suzuki T, Amemiya N, et al. Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters. Clin Exp Nephrol. 2012;16(5):706\u201312.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"1434_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.ajkd.2008.03.003","volume":"52","author":"MC Foster","year":"2008","unstructured":"Foster MC, Hweng SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham heart study. Am J Kidney Dis. 2008;52(1):39\u201348.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1434_CR16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0272-6386(01)80120-7","volume":"37","author":"F Bonnet","year":"2001","unstructured":"Bonnet F, Deprele C, Sassolas A, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis. 2001;37(4):720\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1434_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10157-014-0993-y","volume":"19","author":"Yuriko Yonekura","year":"2014","unstructured":"Yonekura Y, Goto S, Sugiyama H, Kitamura H. The influences of larger physical constitutions including obesity on the amount of urine protein excretion in primary glomerulonephritis: research of the Japan renal biopsy registry. Clin Exp Nephrol. 2015;19(3).","journal-title":"Clinical and Experimental Nephrology"},{"key":"1434_CR18","volume-title":"Government report","author":"The Scottish Government. Scottish Index of Multiple Deprivation","year":"2012","unstructured":"The Scottish Government. Scottish Index of Multiple Deprivation. Government report. Edinburgh: The Scottish Government, Statistics; 2012."},{"issue":"2","key":"1434_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1037\/1082-989X.7.2.147","volume":"7","author":"JGJ Schafer","year":"2002","unstructured":"Schafer JGJ. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147\u201377.","journal-title":"Psychol Methods"},{"key":"1434_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"1434_CR21","volume-title":"Analysis of survival data","author":"DR Cox","year":"1984","unstructured":"Cox DR, Oakes D. Analysis of survival data. 1st ed. London: Chapman and Hall\/CRC; 1984.","edition":"1"},{"issue":"11","key":"1434_CR22","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/ndt\/gft355","volume":"28","author":"M Noordzij","year":"2013","unstructured":"Noordzij M, Leffondre K, van Stralen K, Zoccali C, Dekker F, Jager K. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28(11):2670\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1434_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1152\/ajprenal.00110.2008","volume":"296","author":"N Deji","year":"2009","unstructured":"Deji N, Kume S, Soumura M, et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 2009;296(1):118\u201326.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"1434_CR24","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1681\/ASN.2011010026","volume":"22","author":"AE Decleves","year":"2011","unstructured":"Decleves AE, Mathew AV, Cunard R, Sharma K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol. 2011;22(10):1846\u201355.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1434_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1440-1681.1998.tb02146.x","volume":"25","author":"JE Hall","year":"2007","unstructured":"Hall JE, Brands MW, Henegar JR, Shek EW. Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol. 2007;25(1):58\u201364.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1434_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1210\/en.2005-0641","volume":"147","author":"Y Wu","year":"2006","unstructured":"Wu Y, Liu Z, Xiang Z. Obesity-related Glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147(1):44\u201350.","journal-title":"Endocrinology."},{"issue":"3","key":"1434_CR27","doi-asserted-by":"publisher","first-page":"e0122009","DOI":"10.1371\/journal.pone.0122009","volume":"10","author":"Cynthia Ciwei Lim","year":"2015","unstructured":"Lim CC, Teo BW, Tai ES, et al. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. PLoS One. 2015;10(3).","journal-title":"PLOS ONE"},{"issue":"12","key":"1434_CR28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. M J Clin Invest. 2004;114(12):1752\u201361.","journal-title":"M J Clin Invest"},{"issue":"12","key":"1434_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneph.2009.184","volume":"5","author":"XZ Ruan","year":"2009","unstructured":"Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 2009;5(12):713\u201321.","journal-title":"Nat Rev Nephrol"},{"issue":"22","key":"1434_CR30","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1001\/archinternmed.2009.438","volume":"169","author":"Cassianne Robinson-Cohen","year":"2009","unstructured":"Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple L, de Boer I, Sarnak M, et al. Physical activity and rapid decline in kidney function among older adults. Arch Intern Med. 2009;169(22).","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"1434_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1681\/ASN.2013040392","volume":"25","author":"C Robinson-Cohen","year":"2014","unstructured":"Robinson-Cohen C, Littman A, Duncan G, Weiss N, Sachs M, Ruzinski J, et al. Physical activity and change in estimated GFR among persons with CKD. J Am Soc Nephrol. 2014;25(2):399\u2013406.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1434_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ndt\/gfw452","volume":"32","author":"Jia Xia","year":"2017","unstructured":"Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrology Dialysis Transplantation. 2017;32(3).","journal-title":"Nephrology Dialysis Transplantation"},{"key":"1434_CR33","unstructured":"Campbell J, MacKinnon B, Traynor JP, et al. The Scottish Renal Registry Annual Report 2016. Glasgow: The Scottish Renal Association; 2017."},{"issue":"3","key":"1434_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.kint.2018.11.026","volume":"95","author":"Hae-Yoon Grace Choung","year":"2019","unstructured":"Choung HG, Bomback AS, Stokes MB, Santoriello DC. The spectrum of kidney biopsy findings in patients with morbid obesity. Kidney Int. 2019;95(3).","journal-title":"Kidney International"},{"key":"1434_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2052-9538-1-9","volume":"1","author":"JA Pasco","year":"2014","unstructured":"Pasco JA, Holloway KL, Dobbins A, et al. Body mass index and measures of body fat for defining obesity and underweight: a cross-sectional, population-based study. BMC Obesity. 2014;1:9.","journal-title":"BMC Obesity"},{"key":"1434_CR36","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/S0140-6736(18)30781-5","volume":"391","author":"M Ezzati","year":"2018","unstructured":"Ezzati M, Di Cesare M, Bentham J, et al. Determining the worldwide prevalence of obesity: authors reply. Lancet. 2018;391:1774.","journal-title":"Lancet."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1434-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1434-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1434-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T23:56:29Z","timestamp":1593561389000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1434-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1434-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"31 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required on the basis that this was analysis of routine clinical data. Data were fully anonymised and Caldicott Guardian approval was granted by the information governance manager of NHS Greater Glasgow and Clyde.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CCG reports honorarium from Retrophin Inc., outside the submitted work. JSL is funded by a Kidney Research UK Training Fellowship (TF_013_20161125) and supported by a British Heart Foundation Centre of Excellence Award (RE\/13\/5\/30177). JSL has received lectureship honorarium from Vifor Fresenius and Bristol-Myers Squibb.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}